Elevance Health, Inc. insider trading
ELV$386.43+4.76 (+1.25%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+13.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
- GBGail Boudreaux0.0793%
- FFFelicia F. Norwood0.0179%
- MKMark Kaye0.0148%
- PDPeter D. Haytaian0.0126%
- RLRatnakar Lavu0.0074%
- BWBlair Williams Todt0.0072%
- LHLewis Hay III0.0056%
- CMCharles Morgan Kendrick Jr.0.0054%
- RGRamiro G. Peru0.005%
- RLRobert L. Dixon Jr.0.005%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| ELV | Gail Boudreaux | Open market purchase$753K | +1.2% | $368.25 | $753K | Jul 17, 2026 | Jul 17, 2026 |
| ELV | Gail Boudreaux | Open market purchase$249K | +0.4% | $366.41 | $249K | Jul 17, 2026 | Jul 17, 2026 |
| ELV | Ramiro G. Peru | Open market purchase$366K | +10.1% | $366.05 | $366K | Jul 17, 2026 | Jul 17, 2026 |
| ELV | Ronald W. Penczek | Open market sell$149K | -9.0% | $403.16 | $149K | Jun 12, 2026 | Jun 15, 2026 |
| ELV | Robert L. Dixon Jr. | Open market sell$60.7K | -1.4% | $401.77 | $60.7K | Jun 11, 2026 | Jun 12, 2026 |
| ELV | Amy W. Schulman | Open market sell$7.48K | -10.7% | $287.50 | $7.48K | Mar 12, 2026 | Mar 23, 2026 |
| ELV | Charles Morgan Kendrick Jr. | Open market sell$911K | -21.3% | $284.92 | $911K | Mar 6, 2026 | Mar 9, 2026 |
| ELV | Steven H. Collis | Open market purchase$870K | +469.5% | $289.84 | $870K | Mar 5, 2026 | Mar 6, 2026 |